MARATTO

article · European Journal of Cancer

Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics

202410 citationsOpen accessUniversity of the Free State

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • PARP inhibition in cancer therapy
  • DNA Repair Mechanisms
  • Toxin Mechanisms and Immunotoxins

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ejca.2024.115169

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.